Lower resolutions will be available first, followed by higher resolutions.
Video unavailable.
This video either does not exist, or the owner has made it private.
Password required
Skip
Viewer discretion is advised.
This video may contain offensive or misleading content, and is only intended for mature audiences.
Vancouver Investor Summit 2023 Keynote Speaker
Keith Gillard is co-founder and CEO of UpperStage.Capital Inc., an impact-focused private equity firm boosting profitable companies to their next level of success. He is an entrepreneur and investment professional who has focused more than twenty years on impact investment. Mr. Gillard has provided leadership on the board of directors of dozens of companies, funds, and not-for-profit organizations. He is a proven fund-raiser, deal-maker, and business development matchmaker with an extensive international network, having close relationships with multinational organizations and leading investors across North America, Asia, and Europe.
Lower resolutions will be available first, followed by higher resolutions.
Video unavailable.
This video either does not exist, or the owner has made it private.
Password required
Skip
Viewer discretion is advised.
This video may contain offensive or misleading content, and is only intended for mature audiences.
Vancouver Investor Summit 2023 Keynote Speaker
Keith Gillard is co-founder and CEO of UpperStage.Capital Inc., an impact-focused private equity firm boosting profitable companies to their next level of success. He is an entrepreneur and investment professional who has focused more than twenty years on impact investment. Mr. Gillard has provided leadership on the board of directors of dozens of companies, funds, and not-for-profit organizations. He is a proven fund-raiser, deal-maker, and business development matchmaker with an extensive international network, having close relationships with multinational organizations and leading investors across North America, Asia, and Europe.
Lower resolutions will be available first, followed by higher resolutions.
Video unavailable.
This video either does not exist, or the owner has made it private.
Password required
Skip
Viewer discretion is advised.
This video may contain offensive or misleading content, and is only intended for mature audiences.
Dr. Chris Apfel is the founder and CEO of SageMedic Corp., an early-stage clinical diagnostics company to assist oncologists in selecting the most effective treatment for their patients. Prior to starting SageMedic, he was a Professor in the Department of Anesthesia at UCSF, where he worked as a clinician and led the Clinical Research Core. Dr. Apfel is a nationally and internationally known authority on designing, conducting, and publishing highest quality clinical trials with thousands of patients that have changed medical practice with over 100 peer-reviewed publications. Most notable, he developed the “Apfel Score,” a standard tool that is now used in clinical practice world-wide. He also teaches clinical trial design as an Adjunct Associate Professor at UCSF and is the Chair of the Life Science Committee at the Keiretsu Angel Investment Forum and a member of Life Science Angels in the Bay Area.
Dr. Apfel is a California licensed physician with 20+ years of clinical experience in anesthesiology, critical care medicine, and emergency medicine. He received his medical degree (MD) and his doctoral degree (PhD equivalent) from Justus-Liebig-Universität Giessen, Germany, and his Master of Business Administration (MBA) from the Wharton School of Business, University of Pennsylvania, PA.
How to Pick Winners In Life Sciences with Dr. Christian Apfel
Dr. Chris Apfel is the founder and CEO of SageMedic Corp., an early-stage clinical diagnostics company to assist oncologists in selecting the most effective treatment for their patients. Prior to starting SageMedic, he was a Professor in the Department of Anesthesia at UCSF, where he worked as a clinician and led the Clinical Research Core. Dr. Apfel is a nationally and internationally known authority on designing, conducting, and publishing highest quality clinical trials with thousands of patients that have changed medical practice with over 100 peer-reviewed publications. Most notable, he developed the “Apfel Score,” a standard tool that is now used in clinical practice world-wide. He also teaches clinical trial design as an Adjunct Associate Professor at UCSF and is the Chair of the Life Science Committee at the Keiretsu Angel Investment Forum and a member of Life Science Angels in the Bay Area.
Dr. Apfel is a California licensed physician with 20+ years of clinical experience in anesthesiology, critical care medicine, and emergency medicine. He received his medical degree (MD) and his doctoral degree (PhD equivalent) from Justus-Liebig-Universität Giessen, Germany, and his Master of Business Administration (MBA) from the Wharton School of Business, University of Pennsylvania, PA.
Link to your social media accounts